nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP2C19—epilepsy syndrome	0.135	0.48	CbGaD
Norethindrone—ALB—epilepsy syndrome	0.0752	0.266	CbGaD
Norethindrone—ABCB1—epilepsy syndrome	0.0717	0.254	CbGaD
Norethindrone—ALB—Oxcarbazepine—epilepsy syndrome	0.0208	0.0385	CbGbCtD
Norethindrone—ALB—Fosphenytoin—epilepsy syndrome	0.0182	0.0337	CbGbCtD
Norethindrone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0167	0.031	CbGbCtD
Norethindrone—ALB—Clonazepam—epilepsy syndrome	0.0164	0.0305	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.014	0.0259	CbGbCtD
Norethindrone—CYP3A7—Carbamazepine—epilepsy syndrome	0.014	0.0259	CbGbCtD
Norethindrone—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0135	0.025	CbGbCtD
Norethindrone—ALB—Rufinamide—epilepsy syndrome	0.0134	0.0248	CbGbCtD
Norethindrone—CYP3A7—Phenytoin—epilepsy syndrome	0.0125	0.0233	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0125	0.0233	CbGbCtD
Norethindrone—CYP2C19—Trimethadione—epilepsy syndrome	0.0125	0.0232	CbGbCtD
Norethindrone—CYP2C19—Felbamate—epilepsy syndrome	0.0125	0.0232	CbGbCtD
Norethindrone—ABCB1—Levetiracetam—epilepsy syndrome	0.0119	0.022	CbGbCtD
Norethindrone—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0118	0.0218	CbGbCtD
Norethindrone—ALB—Phenytoin—epilepsy syndrome	0.0117	0.0217	CbGbCtD
Norethindrone—CYP3A7—Phenobarbital—epilepsy syndrome	0.0112	0.0207	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0112	0.0207	CbGbCtD
Norethindrone—CYP3A7—Midazolam—epilepsy syndrome	0.011	0.0204	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.011	0.0204	CbGbCtD
Norethindrone—ALB—Propofol—epilepsy syndrome	0.0109	0.0202	CbGbCtD
Norethindrone—CYP3A7—Diazepam—epilepsy syndrome	0.0106	0.0197	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0106	0.0197	CbGbCtD
Norethindrone—CYP3A5—Carbamazepine—epilepsy syndrome	0.0105	0.0195	CbGbCtD
Norethindrone—CYP2C19—Clobazam—epilepsy syndrome	0.0102	0.0189	CbGbCtD
Norethindrone—ALB—Diazepam—epilepsy syndrome	0.00989	0.0183	CbGbCtD
Norethindrone—CYP3A5—Phenytoin—epilepsy syndrome	0.00941	0.0174	CbGbCtD
Norethindrone—CYP2C19—Carbamazepine—epilepsy syndrome	0.00846	0.0157	CbGbCtD
Norethindrone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00839	0.0156	CbGbCtD
Norethindrone—CYP3A5—Midazolam—epilepsy syndrome	0.00827	0.0153	CbGbCtD
Norethindrone—ABCB1—Clobazam—epilepsy syndrome	0.00824	0.0153	CbGbCtD
Norethindrone—CYP3A5—Diazepam—epilepsy syndrome	0.00795	0.0147	CbGbCtD
Norethindrone—ABCB1—Lamotrigine—epilepsy syndrome	0.00793	0.0147	CbGbCtD
Norethindrone—CYP2C19—Primidone—epilepsy syndrome	0.0079	0.0146	CbGbCtD
Norethindrone—CYP2C19—Phenytoin—epilepsy syndrome	0.00759	0.0141	CbGbCtD
Norethindrone—CYP2C19—Propofol—epilepsy syndrome	0.00708	0.0131	CbGbCtD
Norethindrone—ABCB1—Carbamazepine—epilepsy syndrome	0.00683	0.0127	CbGbCtD
Norethindrone—CYP2C19—Phenobarbital—epilepsy syndrome	0.00676	0.0125	CbGbCtD
Norethindrone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00651	0.0121	CbGbCtD
Norethindrone—CYP2C19—Diazepam—epilepsy syndrome	0.00641	0.0119	CbGbCtD
Norethindrone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00627	0.0116	CbGbCtD
Norethindrone—CYP2C19—Zonisamide—epilepsy syndrome	0.00626	0.0116	CbGbCtD
Norethindrone—ABCB1—Phenytoin—epilepsy syndrome	0.00612	0.0114	CbGbCtD
Norethindrone—CYP3A4—Trimethadione—epilepsy syndrome	0.00606	0.0112	CbGbCtD
Norethindrone—CYP3A4—Felbamate—epilepsy syndrome	0.00606	0.0112	CbGbCtD
Norethindrone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00569	0.0106	CbGbCtD
Norethindrone—ABCB1—Phenobarbital—epilepsy syndrome	0.00546	0.0101	CbGbCtD
Norethindrone—ABCB1—Midazolam—epilepsy syndrome	0.00538	0.00998	CbGbCtD
Norethindrone—ABCB1—Diazepam—epilepsy syndrome	0.00517	0.00959	CbGbCtD
Norethindrone—CYP3A4—Clonazepam—epilepsy syndrome	0.00515	0.00955	CbGbCtD
Norethindrone—CYP2C19—Valproic Acid—epilepsy syndrome	0.00505	0.00937	CbGbCtD
Norethindrone—CYP3A4—Clobazam—epilepsy syndrome	0.00494	0.00915	CbGbCtD
Norethindrone—CYP2C19—Topiramate—epilepsy syndrome	0.00456	0.00846	CbGbCtD
Norethindrone—CYP3A4—Rufinamide—epilepsy syndrome	0.0042	0.00778	CbGbCtD
Norethindrone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00409	0.00759	CbGbCtD
Norethindrone—CYP3A4—Primidone—epilepsy syndrome	0.00382	0.00708	CbGbCtD
Norethindrone—CYP3A4—Phenytoin—epilepsy syndrome	0.00367	0.0068	CbGbCtD
Norethindrone—CYP3A4—Propofol—epilepsy syndrome	0.00342	0.00635	CbGbCtD
Norethindrone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00327	0.00606	CbGbCtD
Norethindrone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00327	0.00606	CbGbCtD
Norethindrone—CYP3A4—Midazolam—epilepsy syndrome	0.00322	0.00598	CbGbCtD
Norethindrone—CYP3A4—Diazepam—epilepsy syndrome	0.0031	0.00575	CbGbCtD
Norethindrone—CYP3A4—Zonisamide—epilepsy syndrome	0.00303	0.00561	CbGbCtD
Norethindrone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00244	0.00453	CbGbCtD
Norethindrone—CYP3A4—Topiramate—epilepsy syndrome	0.0022	0.00409	CbGbCtD
Norethindrone—Danazol—CCL2—epilepsy syndrome	0.000312	0.124	CrCbGaD
Norethindrone—Norgestimate—ABCC2—epilepsy syndrome	0.000248	0.0988	CrCbGaD
Norethindrone—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.000244	0.0973	CrCbGaD
Norethindrone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000184	0.0733	CrCbGaD
Norethindrone—Drospirenone—BCHE—epilepsy syndrome	0.000175	0.0696	CrCbGaD
Norethindrone—Cortisone acetate—NR3C1—epilepsy syndrome	0.000169	0.0671	CrCbGaD
Norethindrone—Testosterone—SLCO1A2—epilepsy syndrome	0.000142	0.0565	CrCbGaD
Norethindrone—Ethinyl Estradiol—ABCC2—epilepsy syndrome	0.000128	0.051	CrCbGaD
Norethindrone—Testosterone—CYP11A1—epilepsy syndrome	0.000123	0.0491	CrCbGaD
Norethindrone—Fluoxymesterone—NR3C1—epilepsy syndrome	0.00011	0.044	CrCbGaD
Norethindrone—Somnolence—Carbamazepine—epilepsy syndrome	9.15e-05	0.000641	CcSEcCtD
Norethindrone—Urticaria—Felbamate—epilepsy syndrome	9.15e-05	0.00064	CcSEcCtD
Norethindrone—Abdominal pain—Felbamate—epilepsy syndrome	9.1e-05	0.000637	CcSEcCtD
Norethindrone—Vomiting—Acetazolamide—epilepsy syndrome	9.1e-05	0.000637	CcSEcCtD
Norethindrone—Immune system disorder—Pregabalin—epilepsy syndrome	9.09e-05	0.000636	CcSEcCtD
Norethindrone—Pruritus—Levetiracetam—epilepsy syndrome	9.09e-05	0.000636	CcSEcCtD
Norethindrone—Connective tissue disorder—Gabapentin—epilepsy syndrome	9.07e-05	0.000635	CcSEcCtD
Norethindrone—Dyspepsia—Carbamazepine—epilepsy syndrome	9.06e-05	0.000634	CcSEcCtD
Norethindrone—Insomnia—Lamotrigine—epilepsy syndrome	9e-05	0.00063	CcSEcCtD
Norethindrone—Headache—Acetazolamide—epilepsy syndrome	8.96e-05	0.000627	CcSEcCtD
Norethindrone—Urticaria—Zonisamide—epilepsy syndrome	8.95e-05	0.000627	CcSEcCtD
Norethindrone—Abdominal pain—Zonisamide—epilepsy syndrome	8.91e-05	0.000623	CcSEcCtD
Norethindrone—Hypersensitivity—Vigabatrin—epilepsy syndrome	8.9e-05	0.000623	CcSEcCtD
Norethindrone—Asthenia—Fosphenytoin—epilepsy syndrome	8.89e-05	0.000622	CcSEcCtD
Norethindrone—Alopecia—Pregabalin—epilepsy syndrome	8.89e-05	0.000622	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	8.89e-05	0.000622	CcSEcCtD
Norethindrone—Gastrointestinal pain—Clonazepam—epilepsy syndrome	8.88e-05	0.000622	CcSEcCtD
Norethindrone—Fatigue—Carbamazepine—epilepsy syndrome	8.88e-05	0.000621	CcSEcCtD
Norethindrone—Photosensitivity reaction—Topiramate—epilepsy syndrome	8.85e-05	0.00062	CcSEcCtD
Norethindrone—Somnolence—Lamotrigine—epilepsy syndrome	8.85e-05	0.000619	CcSEcCtD
Norethindrone—Weight increased—Topiramate—epilepsy syndrome	8.83e-05	0.000618	CcSEcCtD
Norethindrone—Mental disorder—Pregabalin—epilepsy syndrome	8.82e-05	0.000617	CcSEcCtD
Norethindrone—Dizziness—Propofol—epilepsy syndrome	8.79e-05	0.000615	CcSEcCtD
Norethindrone—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	8.77e-05	0.000614	CcSEcCtD
Norethindrone—Pruritus—Fosphenytoin—epilepsy syndrome	8.77e-05	0.000614	CcSEcCtD
Norethindrone—Hypersensitivity—Diazepam—epilepsy syndrome	8.76e-05	0.000613	CcSEcCtD
Norethindrone—Dyspepsia—Lamotrigine—epilepsy syndrome	8.76e-05	0.000613	CcSEcCtD
Norethindrone—Erythema multiforme—Gabapentin—epilepsy syndrome	8.72e-05	0.000611	CcSEcCtD
Norethindrone—Asthenia—Vigabatrin—epilepsy syndrome	8.67e-05	0.000607	CcSEcCtD
Norethindrone—Flatulence—Pregabalin—epilepsy syndrome	8.63e-05	0.000604	CcSEcCtD
Norethindrone—Urticaria—Clonazepam—epilepsy syndrome	8.63e-05	0.000604	CcSEcCtD
Norethindrone—Depression—Topiramate—epilepsy syndrome	8.62e-05	0.000603	CcSEcCtD
Norethindrone—Dizziness—Midazolam—epilepsy syndrome	8.6e-05	0.000602	CcSEcCtD
Norethindrone—Tension—Pregabalin—epilepsy syndrome	8.6e-05	0.000602	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	8.59e-05	0.000601	CcSEcCtD
Norethindrone—Abdominal pain—Clonazepam—epilepsy syndrome	8.58e-05	0.000601	CcSEcCtD
Norethindrone—Fatigue—Lamotrigine—epilepsy syndrome	8.58e-05	0.0006	CcSEcCtD
Norethindrone—Urticaria—Phenytoin—epilepsy syndrome	8.57e-05	0.0006	CcSEcCtD
Norethindrone—Pruritus—Vigabatrin—epilepsy syndrome	8.55e-05	0.000598	CcSEcCtD
Norethindrone—Asthenia—Diazepam—epilepsy syndrome	8.53e-05	0.000597	CcSEcCtD
Norethindrone—Urticaria—Oxcarbazepine—epilepsy syndrome	8.52e-05	0.000597	CcSEcCtD
Norethindrone—Nervousness—Pregabalin—epilepsy syndrome	8.51e-05	0.000595	CcSEcCtD
Norethindrone—Renal failure—Topiramate—epilepsy syndrome	8.5e-05	0.000595	CcSEcCtD
Norethindrone—Nausea—Acetazolamide—epilepsy syndrome	8.5e-05	0.000595	CcSEcCtD
Norethindrone—Dizziness—Levetiracetam—epilepsy syndrome	8.49e-05	0.000594	CcSEcCtD
Norethindrone—Abdominal pain—Oxcarbazepine—epilepsy syndrome	8.48e-05	0.000594	CcSEcCtD
Norethindrone—Vomiting—Propofol—epilepsy syndrome	8.45e-05	0.000591	CcSEcCtD
Norethindrone—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	8.42e-05	0.000589	CcSEcCtD
Norethindrone—Pruritus—Diazepam—epilepsy syndrome	8.41e-05	0.000589	CcSEcCtD
Norethindrone—Rash—Propofol—epilepsy syndrome	8.38e-05	0.000587	CcSEcCtD
Norethindrone—Dermatitis—Propofol—epilepsy syndrome	8.37e-05	0.000586	CcSEcCtD
Norethindrone—Immune system disorder—Gabapentin—epilepsy syndrome	8.33e-05	0.000583	CcSEcCtD
Norethindrone—Headache—Propofol—epilepsy syndrome	8.33e-05	0.000583	CcSEcCtD
Norethindrone—Hypersensitivity—Zonisamide—epilepsy syndrome	8.3e-05	0.000581	CcSEcCtD
Norethindrone—Vomiting—Midazolam—epilepsy syndrome	8.27e-05	0.000579	CcSEcCtD
Norethindrone—Asthenia—Felbamate—epilepsy syndrome	8.26e-05	0.000578	CcSEcCtD
Norethindrone—Rash—Midazolam—epilepsy syndrome	8.2e-05	0.000574	CcSEcCtD
Norethindrone—Dizziness—Fosphenytoin—epilepsy syndrome	8.2e-05	0.000574	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.19e-05	0.000573	CcSEcCtD
Norethindrone—Dermatitis—Midazolam—epilepsy syndrome	8.19e-05	0.000573	CcSEcCtD
Norethindrone—Urticaria—Carbamazepine—epilepsy syndrome	8.18e-05	0.000573	CcSEcCtD
Norethindrone—Vomiting—Levetiracetam—epilepsy syndrome	8.17e-05	0.000571	CcSEcCtD
Norethindrone—Alopecia—Gabapentin—epilepsy syndrome	8.15e-05	0.000571	CcSEcCtD
Norethindrone—Headache—Midazolam—epilepsy syndrome	8.15e-05	0.00057	CcSEcCtD
Norethindrone—Pruritus—Felbamate—epilepsy syndrome	8.14e-05	0.00057	CcSEcCtD
Norethindrone—Abdominal pain—Carbamazepine—epilepsy syndrome	8.14e-05	0.00057	CcSEcCtD
Norethindrone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.14e-05	0.00057	CcSEcCtD
Norethindrone—Rash—Levetiracetam—epilepsy syndrome	8.1e-05	0.000567	CcSEcCtD
Norethindrone—Dermatitis—Levetiracetam—epilepsy syndrome	8.09e-05	0.000566	CcSEcCtD
Norethindrone—Asthenia—Zonisamide—epilepsy syndrome	8.08e-05	0.000566	CcSEcCtD
Norethindrone—Mental disorder—Gabapentin—epilepsy syndrome	8.08e-05	0.000566	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—epilepsy syndrome	8.05e-05	0.0321	CrCbGaD
Norethindrone—Headache—Levetiracetam—epilepsy syndrome	8.05e-05	0.000563	CcSEcCtD
Norethindrone—Hypersensitivity—Clonazepam—epilepsy syndrome	8e-05	0.00056	CcSEcCtD
Norethindrone—Dizziness—Vigabatrin—epilepsy syndrome	7.99e-05	0.000559	CcSEcCtD
Norethindrone—Pruritus—Zonisamide—epilepsy syndrome	7.97e-05	0.000558	CcSEcCtD
Norethindrone—Hypersensitivity—Phenytoin—epilepsy syndrome	7.95e-05	0.000556	CcSEcCtD
Norethindrone—Flatulence—Gabapentin—epilepsy syndrome	7.92e-05	0.000554	CcSEcCtD
Norethindrone—Oedema—Valproic Acid—epilepsy syndrome	7.91e-05	0.000553	CcSEcCtD
Norethindrone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.91e-05	0.000553	CcSEcCtD
Norethindrone—Urticaria—Lamotrigine—epilepsy syndrome	7.91e-05	0.000553	CcSEcCtD
Norethindrone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.000553	CcSEcCtD
Norethindrone—Nausea—Propofol—epilepsy syndrome	7.9e-05	0.000553	CcSEcCtD
Norethindrone—Tension—Gabapentin—epilepsy syndrome	7.88e-05	0.000552	CcSEcCtD
Norethindrone—Vomiting—Fosphenytoin—epilepsy syndrome	7.88e-05	0.000552	CcSEcCtD
Norethindrone—Abdominal pain—Lamotrigine—epilepsy syndrome	7.87e-05	0.000551	CcSEcCtD
Norethindrone—Dizziness—Diazepam—epilepsy syndrome	7.87e-05	0.00055	CcSEcCtD
Norethindrone—Rash—Fosphenytoin—epilepsy syndrome	7.81e-05	0.000547	CcSEcCtD
Norethindrone—Dermatitis—Fosphenytoin—epilepsy syndrome	7.81e-05	0.000546	CcSEcCtD
Norethindrone—Haemoglobin—Topiramate—epilepsy syndrome	7.8e-05	0.000546	CcSEcCtD
Norethindrone—Nervousness—Gabapentin—epilepsy syndrome	7.8e-05	0.000546	CcSEcCtD
Norethindrone—Asthenia—Clonazepam—epilepsy syndrome	7.79e-05	0.000545	CcSEcCtD
Norethindrone—Hydrocortisone—ABCG2—epilepsy syndrome	7.78e-05	0.031	CrCbGaD
Norethindrone—Headache—Fosphenytoin—epilepsy syndrome	7.76e-05	0.000543	CcSEcCtD
Norethindrone—Haemorrhage—Topiramate—epilepsy syndrome	7.76e-05	0.000543	CcSEcCtD
Norethindrone—Hepatitis—Topiramate—epilepsy syndrome	7.76e-05	0.000543	CcSEcCtD
Norethindrone—Asthenia—Phenytoin—epilepsy syndrome	7.74e-05	0.000542	CcSEcCtD
Norethindrone—Nausea—Midazolam—epilepsy syndrome	7.72e-05	0.000541	CcSEcCtD
Norethindrone—Asthenia—Oxcarbazepine—epilepsy syndrome	7.7e-05	0.000539	CcSEcCtD
Norethindrone—Pruritus—Clonazepam—epilepsy syndrome	7.68e-05	0.000538	CcSEcCtD
Norethindrone—Vomiting—Vigabatrin—epilepsy syndrome	7.68e-05	0.000538	CcSEcCtD
Norethindrone—Skin disorder—Valproic Acid—epilepsy syndrome	7.68e-05	0.000538	CcSEcCtD
Norethindrone—Pruritus—Phenytoin—epilepsy syndrome	7.63e-05	0.000534	CcSEcCtD
Norethindrone—Connective tissue disorder—Topiramate—epilepsy syndrome	7.63e-05	0.000534	CcSEcCtD
Norethindrone—Nausea—Levetiracetam—epilepsy syndrome	7.63e-05	0.000534	CcSEcCtD
Norethindrone—Rash—Vigabatrin—epilepsy syndrome	7.62e-05	0.000533	CcSEcCtD
Norethindrone—Dizziness—Felbamate—epilepsy syndrome	7.61e-05	0.000533	CcSEcCtD
Norethindrone—Dermatitis—Vigabatrin—epilepsy syndrome	7.61e-05	0.000533	CcSEcCtD
Norethindrone—Pruritus—Oxcarbazepine—epilepsy syndrome	7.59e-05	0.000531	CcSEcCtD
Norethindrone—Convulsion—Pregabalin—epilepsy syndrome	7.59e-05	0.000531	CcSEcCtD
Norethindrone—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.59e-05	0.000531	CcSEcCtD
Norethindrone—Headache—Vigabatrin—epilepsy syndrome	7.57e-05	0.00053	CcSEcCtD
Norethindrone—Vomiting—Diazepam—epilepsy syndrome	7.56e-05	0.000529	CcSEcCtD
Norethindrone—Rash—Diazepam—epilepsy syndrome	7.5e-05	0.000525	CcSEcCtD
Norethindrone—Dermatitis—Diazepam—epilepsy syndrome	7.49e-05	0.000524	CcSEcCtD
Norethindrone—Dizziness—Zonisamide—epilepsy syndrome	7.45e-05	0.000522	CcSEcCtD
Norethindrone—Headache—Diazepam—epilepsy syndrome	7.45e-05	0.000522	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.41e-05	0.000518	CcSEcCtD
Norethindrone—Asthenia—Carbamazepine—epilepsy syndrome	7.39e-05	0.000517	CcSEcCtD
Norethindrone—Nausea—Fosphenytoin—epilepsy syndrome	7.36e-05	0.000515	CcSEcCtD
Norethindrone—Erythema multiforme—Topiramate—epilepsy syndrome	7.34e-05	0.000514	CcSEcCtD
Norethindrone—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.33e-05	0.000513	CcSEcCtD
Norethindrone—Vomiting—Felbamate—epilepsy syndrome	7.32e-05	0.000512	CcSEcCtD
Norethindrone—Pruritus—Carbamazepine—epilepsy syndrome	7.28e-05	0.00051	CcSEcCtD
Norethindrone—Rash—Felbamate—epilepsy syndrome	7.26e-05	0.000508	CcSEcCtD
Norethindrone—Dermatitis—Felbamate—epilepsy syndrome	7.25e-05	0.000508	CcSEcCtD
Norethindrone—Headache—Felbamate—epilepsy syndrome	7.21e-05	0.000505	CcSEcCtD
Norethindrone—Dizziness—Clonazepam—epilepsy syndrome	7.18e-05	0.000503	CcSEcCtD
Norethindrone—Nausea—Vigabatrin—epilepsy syndrome	7.18e-05	0.000502	CcSEcCtD
Norethindrone—Vomiting—Zonisamide—epilepsy syndrome	7.16e-05	0.000501	CcSEcCtD
Norethindrone—Insomnia—Valproic Acid—epilepsy syndrome	7.15e-05	0.000501	CcSEcCtD
Norethindrone—Oedema—Pregabalin—epilepsy syndrome	7.15e-05	0.0005	CcSEcCtD
Norethindrone—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.15e-05	0.0005	CcSEcCtD
Norethindrone—Asthenia—Lamotrigine—epilepsy syndrome	7.14e-05	0.0005	CcSEcCtD
Norethindrone—Dizziness—Phenytoin—epilepsy syndrome	7.13e-05	0.000499	CcSEcCtD
Norethindrone—Rash—Zonisamide—epilepsy syndrome	7.1e-05	0.000497	CcSEcCtD
Norethindrone—Dermatitis—Zonisamide—epilepsy syndrome	7.1e-05	0.000497	CcSEcCtD
Norethindrone—Dizziness—Oxcarbazepine—epilepsy syndrome	7.1e-05	0.000497	CcSEcCtD
Norethindrone—Nausea—Diazepam—epilepsy syndrome	7.06e-05	0.000494	CcSEcCtD
Norethindrone—Headache—Zonisamide—epilepsy syndrome	7.06e-05	0.000494	CcSEcCtD
Norethindrone—Pruritus—Lamotrigine—epilepsy syndrome	7.04e-05	0.000493	CcSEcCtD
Norethindrone—Somnolence—Valproic Acid—epilepsy syndrome	7.03e-05	0.000492	CcSEcCtD
Norethindrone—Immune system disorder—Topiramate—epilepsy syndrome	7.01e-05	0.000491	CcSEcCtD
Norethindrone—Dyspepsia—Valproic Acid—epilepsy syndrome	6.96e-05	0.000487	CcSEcCtD
Norethindrone—Convulsion—Gabapentin—epilepsy syndrome	6.96e-05	0.000487	CcSEcCtD
Norethindrone—Skin disorder—Pregabalin—epilepsy syndrome	6.94e-05	0.000486	CcSEcCtD
Norethindrone—Vomiting—Clonazepam—epilepsy syndrome	6.9e-05	0.000483	CcSEcCtD
Norethindrone—Alopecia—Topiramate—epilepsy syndrome	6.86e-05	0.00048	CcSEcCtD
Norethindrone—Vomiting—Phenytoin—epilepsy syndrome	6.86e-05	0.00048	CcSEcCtD
Norethindrone—Rash—Clonazepam—epilepsy syndrome	6.85e-05	0.000479	CcSEcCtD
Norethindrone—Dermatitis—Clonazepam—epilepsy syndrome	6.84e-05	0.000479	CcSEcCtD
Norethindrone—Nausea—Felbamate—epilepsy syndrome	6.84e-05	0.000479	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.83e-05	0.000478	CcSEcCtD
Norethindrone—Vomiting—Oxcarbazepine—epilepsy syndrome	6.82e-05	0.000477	CcSEcCtD
Norethindrone—Fatigue—Valproic Acid—epilepsy syndrome	6.82e-05	0.000477	CcSEcCtD
Norethindrone—Dizziness—Carbamazepine—epilepsy syndrome	6.81e-05	0.000477	CcSEcCtD
Norethindrone—Headache—Clonazepam—epilepsy syndrome	6.8e-05	0.000476	CcSEcCtD
Norethindrone—Rash—Phenytoin—epilepsy syndrome	6.8e-05	0.000476	CcSEcCtD
Norethindrone—Mental disorder—Topiramate—epilepsy syndrome	6.8e-05	0.000476	CcSEcCtD
Norethindrone—Dermatitis—Phenytoin—epilepsy syndrome	6.8e-05	0.000476	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.79e-05	0.000475	CcSEcCtD
Norethindrone—Rash—Oxcarbazepine—epilepsy syndrome	6.77e-05	0.000474	CcSEcCtD
Norethindrone—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.76e-05	0.000473	CcSEcCtD
Norethindrone—Headache—Phenytoin—epilepsy syndrome	6.76e-05	0.000473	CcSEcCtD
Norethindrone—Headache—Oxcarbazepine—epilepsy syndrome	6.72e-05	0.00047	CcSEcCtD
Norethindrone—Hydrocortisone—NR3C1—epilepsy syndrome	6.71e-05	0.0267	CrCbGaD
Norethindrone—Nausea—Zonisamide—epilepsy syndrome	6.69e-05	0.000468	CcSEcCtD
Norethindrone—Flatulence—Topiramate—epilepsy syndrome	6.66e-05	0.000466	CcSEcCtD
Norethindrone—Tension—Topiramate—epilepsy syndrome	6.63e-05	0.000464	CcSEcCtD
Norethindrone—Dizziness—Lamotrigine—epilepsy syndrome	6.58e-05	0.000461	CcSEcCtD
Norethindrone—Nervousness—Topiramate—epilepsy syndrome	6.56e-05	0.000459	CcSEcCtD
Norethindrone—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.56e-05	0.000459	CcSEcCtD
Norethindrone—Oedema—Gabapentin—epilepsy syndrome	6.56e-05	0.000459	CcSEcCtD
Norethindrone—Vomiting—Carbamazepine—epilepsy syndrome	6.55e-05	0.000458	CcSEcCtD
Norethindrone—Rash—Carbamazepine—epilepsy syndrome	6.49e-05	0.000454	CcSEcCtD
Norethindrone—Dermatitis—Carbamazepine—epilepsy syndrome	6.49e-05	0.000454	CcSEcCtD
Norethindrone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.47e-05	0.000453	CcSEcCtD
Norethindrone—Insomnia—Pregabalin—epilepsy syndrome	6.47e-05	0.000453	CcSEcCtD
Norethindrone—Nausea—Clonazepam—epilepsy syndrome	6.45e-05	0.000451	CcSEcCtD
Norethindrone—Headache—Carbamazepine—epilepsy syndrome	6.45e-05	0.000451	CcSEcCtD
Norethindrone—Nausea—Phenytoin—epilepsy syndrome	6.41e-05	0.000448	CcSEcCtD
Norethindrone—Nausea—Oxcarbazepine—epilepsy syndrome	6.37e-05	0.000446	CcSEcCtD
Norethindrone—Skin disorder—Gabapentin—epilepsy syndrome	6.37e-05	0.000446	CcSEcCtD
Norethindrone—Somnolence—Pregabalin—epilepsy syndrome	6.36e-05	0.000445	CcSEcCtD
Norethindrone—Vomiting—Lamotrigine—epilepsy syndrome	6.33e-05	0.000443	CcSEcCtD
Norethindrone—Urticaria—Valproic Acid—epilepsy syndrome	6.28e-05	0.00044	CcSEcCtD
Norethindrone—Rash—Lamotrigine—epilepsy syndrome	6.27e-05	0.000439	CcSEcCtD
Norethindrone—Dermatitis—Lamotrigine—epilepsy syndrome	6.27e-05	0.000439	CcSEcCtD
Norethindrone—Abdominal pain—Valproic Acid—epilepsy syndrome	6.25e-05	0.000438	CcSEcCtD
Norethindrone—Headache—Lamotrigine—epilepsy syndrome	6.23e-05	0.000436	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.17e-05	0.000432	CcSEcCtD
Norethindrone—Fatigue—Pregabalin—epilepsy syndrome	6.16e-05	0.000431	CcSEcCtD
Norethindrone—Nausea—Carbamazepine—epilepsy syndrome	6.12e-05	0.000428	CcSEcCtD
Norethindrone—Testosterone—ABCG2—epilepsy syndrome	5.99e-05	0.0239	CrCbGaD
Norethindrone—Insomnia—Gabapentin—epilepsy syndrome	5.93e-05	0.000415	CcSEcCtD
Norethindrone—Nausea—Lamotrigine—epilepsy syndrome	5.91e-05	0.000414	CcSEcCtD
Norethindrone—Convulsion—Topiramate—epilepsy syndrome	5.86e-05	0.00041	CcSEcCtD
Norethindrone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.85e-05	0.000409	CcSEcCtD
Norethindrone—Somnolence—Gabapentin—epilepsy syndrome	5.83e-05	0.000408	CcSEcCtD
Norethindrone—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.83e-05	0.000408	CcSEcCtD
Norethindrone—Dyspepsia—Gabapentin—epilepsy syndrome	5.77e-05	0.000404	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.71e-05	0.0004	CcSEcCtD
Norethindrone—Urticaria—Pregabalin—epilepsy syndrome	5.68e-05	0.000397	CcSEcCtD
Norethindrone—Asthenia—Valproic Acid—epilepsy syndrome	5.67e-05	0.000397	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.66e-05	0.000396	CcSEcCtD
Norethindrone—Fatigue—Gabapentin—epilepsy syndrome	5.65e-05	0.000396	CcSEcCtD
Norethindrone—Abdominal pain—Pregabalin—epilepsy syndrome	5.65e-05	0.000396	CcSEcCtD
Norethindrone—Pruritus—Valproic Acid—epilepsy syndrome	5.59e-05	0.000392	CcSEcCtD
Norethindrone—Oedema—Topiramate—epilepsy syndrome	5.52e-05	0.000386	CcSEcCtD
Norethindrone—Progesterone—NR3C1—epilepsy syndrome	5.47e-05	0.0218	CrCbGaD
Norethindrone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.36e-05	0.000375	CcSEcCtD
Norethindrone—Skin disorder—Topiramate—epilepsy syndrome	5.36e-05	0.000375	CcSEcCtD
Norethindrone—Hypersensitivity—Pregabalin—epilepsy syndrome	5.27e-05	0.000369	CcSEcCtD
Norethindrone—Dizziness—Valproic Acid—epilepsy syndrome	5.23e-05	0.000366	CcSEcCtD
Norethindrone—Urticaria—Gabapentin—epilepsy syndrome	5.21e-05	0.000364	CcSEcCtD
Norethindrone—Abdominal pain—Gabapentin—epilepsy syndrome	5.18e-05	0.000363	CcSEcCtD
Norethindrone—Asthenia—Pregabalin—epilepsy syndrome	5.13e-05	0.000359	CcSEcCtD
Norethindrone—Pruritus—Pregabalin—epilepsy syndrome	5.06e-05	0.000354	CcSEcCtD
Norethindrone—Vomiting—Valproic Acid—epilepsy syndrome	5.03e-05	0.000352	CcSEcCtD
Norethindrone—Insomnia—Topiramate—epilepsy syndrome	4.99e-05	0.000349	CcSEcCtD
Norethindrone—Rash—Valproic Acid—epilepsy syndrome	4.99e-05	0.000349	CcSEcCtD
Norethindrone—Progesterone—CYP2C19—epilepsy syndrome	4.98e-05	0.0199	CrCbGaD
Norethindrone—Dermatitis—Valproic Acid—epilepsy syndrome	4.98e-05	0.000349	CcSEcCtD
Norethindrone—Headache—Valproic Acid—epilepsy syndrome	4.95e-05	0.000347	CcSEcCtD
Norethindrone—Somnolence—Topiramate—epilepsy syndrome	4.9e-05	0.000343	CcSEcCtD
Norethindrone—Dyspepsia—Topiramate—epilepsy syndrome	4.85e-05	0.00034	CcSEcCtD
Norethindrone—Hypersensitivity—Gabapentin—epilepsy syndrome	4.83e-05	0.000338	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.76e-05	0.000333	CcSEcCtD
Norethindrone—Fatigue—Topiramate—epilepsy syndrome	4.76e-05	0.000333	CcSEcCtD
Norethindrone—Dizziness—Pregabalin—epilepsy syndrome	4.73e-05	0.000331	CcSEcCtD
Norethindrone—Testosterone—CYP2C19—epilepsy syndrome	4.71e-05	0.0188	CrCbGaD
Norethindrone—Ethinyl Estradiol—ABCB1—epilepsy syndrome	4.71e-05	0.0188	CrCbGaD
Norethindrone—Asthenia—Gabapentin—epilepsy syndrome	4.7e-05	0.000329	CcSEcCtD
Norethindrone—Nausea—Valproic Acid—epilepsy syndrome	4.7e-05	0.000329	CcSEcCtD
Norethindrone—Pruritus—Gabapentin—epilepsy syndrome	4.64e-05	0.000325	CcSEcCtD
Norethindrone—Vomiting—Pregabalin—epilepsy syndrome	4.55e-05	0.000318	CcSEcCtD
Norethindrone—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.51e-05	0.000316	CcSEcCtD
Norethindrone—Rash—Pregabalin—epilepsy syndrome	4.51e-05	0.000315	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—epilepsy syndrome	4.51e-05	0.0179	CrCbGaD
Norethindrone—Dermatitis—Pregabalin—epilepsy syndrome	4.5e-05	0.000315	CcSEcCtD
Norethindrone—Headache—Pregabalin—epilepsy syndrome	4.48e-05	0.000313	CcSEcCtD
Norethindrone—Urticaria—Topiramate—epilepsy syndrome	4.38e-05	0.000307	CcSEcCtD
Norethindrone—Abdominal pain—Topiramate—epilepsy syndrome	4.36e-05	0.000305	CcSEcCtD
Norethindrone—Dizziness—Gabapentin—epilepsy syndrome	4.34e-05	0.000303	CcSEcCtD
Norethindrone—Nausea—Pregabalin—epilepsy syndrome	4.25e-05	0.000297	CcSEcCtD
Norethindrone—Vomiting—Gabapentin—epilepsy syndrome	4.17e-05	0.000292	CcSEcCtD
Norethindrone—Rash—Gabapentin—epilepsy syndrome	4.13e-05	0.000289	CcSEcCtD
Norethindrone—Dermatitis—Gabapentin—epilepsy syndrome	4.13e-05	0.000289	CcSEcCtD
Norethindrone—Headache—Gabapentin—epilepsy syndrome	4.11e-05	0.000287	CcSEcCtD
Norethindrone—Hypersensitivity—Topiramate—epilepsy syndrome	4.06e-05	0.000284	CcSEcCtD
Norethindrone—Asthenia—Topiramate—epilepsy syndrome	3.96e-05	0.000277	CcSEcCtD
Norethindrone—Pruritus—Topiramate—epilepsy syndrome	3.9e-05	0.000273	CcSEcCtD
Norethindrone—Nausea—Gabapentin—epilepsy syndrome	3.89e-05	0.000273	CcSEcCtD
Norethindrone—Progesterone—CYP2D6—epilepsy syndrome	3.69e-05	0.0147	CrCbGaD
Norethindrone—Dizziness—Topiramate—epilepsy syndrome	3.65e-05	0.000255	CcSEcCtD
Norethindrone—Vomiting—Topiramate—epilepsy syndrome	3.51e-05	0.000245	CcSEcCtD
Norethindrone—Rash—Topiramate—epilepsy syndrome	3.48e-05	0.000243	CcSEcCtD
Norethindrone—Dermatitis—Topiramate—epilepsy syndrome	3.47e-05	0.000243	CcSEcCtD
Norethindrone—Headache—Topiramate—epilepsy syndrome	3.46e-05	0.000242	CcSEcCtD
Norethindrone—Nausea—Topiramate—epilepsy syndrome	3.28e-05	0.000229	CcSEcCtD
Norethindrone—Hydrocortisone—ABCB1—epilepsy syndrome	3.24e-05	0.0129	CrCbGaD
Norethindrone—Progesterone—ABCB1—epilepsy syndrome	2.64e-05	0.0105	CrCbGaD
Norethindrone—Testosterone—ALB—epilepsy syndrome	2.61e-05	0.0104	CrCbGaD
Norethindrone—Testosterone—ABCB1—epilepsy syndrome	2.49e-05	0.00993	CrCbGaD
Norethindrone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.54e-06	0.000259	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.54e-06	0.000259	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.54e-06	0.000259	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—S100B—epilepsy syndrome	8.52e-06	0.000258	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ST3GAL3—epilepsy syndrome	8.49e-06	0.000257	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AQP1—epilepsy syndrome	8.44e-06	0.000256	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SOCS3—epilepsy syndrome	8.43e-06	0.000256	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDC42—epilepsy syndrome	8.41e-06	0.000255	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ASAH1—epilepsy syndrome	8.4e-06	0.000255	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	8.39e-06	0.000254	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	8.37e-06	0.000254	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	8.34e-06	0.000253	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADSL—epilepsy syndrome	8.31e-06	0.000252	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.31e-06	0.000252	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—STXBP1—epilepsy syndrome	8.17e-06	0.000248	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NT5E—epilepsy syndrome	8.16e-06	0.000247	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALAD—epilepsy syndrome	8.16e-06	0.000247	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GLUL—epilepsy syndrome	8.15e-06	0.000247	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AVP—epilepsy syndrome	8.15e-06	0.000247	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8e-06	0.000242	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CACNA1D—epilepsy syndrome	8e-06	0.000242	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NT5E—epilepsy syndrome	7.97e-06	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALAD—epilepsy syndrome	7.97e-06	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.92e-06	0.00024	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FYN—epilepsy syndrome	7.83e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.82e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.82e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.82e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.82e-06	0.000237	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.79e-06	0.000236	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.79e-06	0.000236	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.77e-06	0.000236	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HES1—epilepsy syndrome	7.7e-06	0.000233	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	7.63e-06	0.000231	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	7.63e-06	0.000231	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.62e-06	0.000231	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.6e-06	0.00023	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.6e-06	0.00023	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—YWHAZ—epilepsy syndrome	7.53e-06	0.000228	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	7.52e-06	0.000228	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FYN—epilepsy syndrome	7.49e-06	0.000227	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TXNRD1—epilepsy syndrome	7.49e-06	0.000227	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.46e-06	0.000226	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	7.46e-06	0.000226	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	7.45e-06	0.000226	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.44e-06	0.000225	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	7.44e-06	0.000225	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.37e-06	0.000223	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GLUL—epilepsy syndrome	7.32e-06	0.000222	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.29e-06	0.000221	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AQP1—epilepsy syndrome	7.27e-06	0.00022	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.27e-06	0.00022	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.27e-06	0.00022	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.24e-06	0.000219	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	7.2e-06	0.000218	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	7.19e-06	0.000218	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	7.16e-06	0.000217	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.14e-06	0.000216	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.14e-06	0.000216	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—BCHE—epilepsy syndrome	7.13e-06	0.000216	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGF—epilepsy syndrome	7.12e-06	0.000216	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	7.08e-06	0.000215	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	7.01e-06	0.000212	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.98e-06	0.000211	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.97e-06	0.000211	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCR5—epilepsy syndrome	6.93e-06	0.00021	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	6.9e-06	0.000209	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.83e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	6.8e-06	0.000206	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.79e-06	0.000206	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	6.78e-06	0.000205	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.73e-06	0.000204	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.72e-06	0.000204	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—TH—epilepsy syndrome	6.71e-06	0.000203	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PLAU—epilepsy syndrome	6.68e-06	0.000202	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CHRM3—epilepsy syndrome	6.57e-06	0.000199	CbGpPWpGaD
Norethindrone—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.57e-06	0.000199	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.56e-06	0.000199	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.52e-06	0.000198	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.52e-06	0.000197	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.48e-06	0.000196	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.48e-06	0.000196	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.48e-06	0.000196	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.48e-06	0.000196	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.48e-06	0.000196	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.46e-06	0.000196	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TSC2—epilepsy syndrome	6.44e-06	0.000195	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AGT—epilepsy syndrome	6.43e-06	0.000195	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.37e-06	0.000193	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOE—epilepsy syndrome	6.3e-06	0.000191	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.27e-06	0.00019	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	6.22e-06	0.000188	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PRKCB—epilepsy syndrome	6.21e-06	0.000188	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KDR—epilepsy syndrome	6.17e-06	0.000187	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS2—epilepsy syndrome	6.14e-06	0.000186	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.12e-06	0.000185	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	6.06e-06	0.000184	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	6.03e-06	0.000183	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6e-06	0.000182	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	5.94e-06	0.00018	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.92e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.92e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.92e-06	0.000179	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	5.92e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.9e-06	0.000179	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.9e-06	0.000179	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.82e-06	0.000176	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.76e-06	0.000174	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.76e-06	0.000174	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.7e-06	0.000173	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.6e-06	0.00017	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.52e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.51e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.51e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.49e-06	0.000166	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.44e-06	0.000165	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—POMC—epilepsy syndrome	5.41e-06	0.000164	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.38e-06	0.000163	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	5.37e-06	0.000163	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCG2—epilepsy syndrome	5.36e-06	0.000162	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCL2—epilepsy syndrome	5.3e-06	0.00016	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2C19—epilepsy syndrome	5.22e-06	0.000158	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP11A1—epilepsy syndrome	5.19e-06	0.000157	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.18e-06	0.000157	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	5.18e-06	0.000157	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—BCHE—epilepsy syndrome	5.16e-06	0.000156	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.15e-06	0.000156	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.04e-06	0.000153	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GPX1—epilepsy syndrome	4.99e-06	0.000151	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.92e-06	0.000149	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.91e-06	0.000149	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.91e-06	0.000149	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.86e-06	0.000147	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TH—epilepsy syndrome	4.85e-06	0.000147	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.81e-06	0.000146	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGF2—epilepsy syndrome	4.79e-06	0.000145	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.69e-06	0.000142	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.68e-06	0.000142	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.68e-06	0.000142	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.68e-06	0.000142	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.66e-06	0.000141	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.62e-06	0.00014	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.58e-06	0.000139	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.58e-06	0.000139	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.55e-06	0.000138	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.49e-06	0.000136	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.46e-06	0.000135	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RELA—epilepsy syndrome	4.44e-06	0.000135	CbGpPWpGaD
Norethindrone—ALB—Metabolism—BCHE—epilepsy syndrome	4.44e-06	0.000135	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.4e-06	0.000133	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.4e-06	0.000133	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.38e-06	0.000133	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MTOR—epilepsy syndrome	4.36e-06	0.000132	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.33e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.32e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—epilepsy syndrome	4.29e-06	0.00013	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A1—epilepsy syndrome	4.24e-06	0.000128	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.22e-06	0.000128	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.2e-06	0.000127	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLCB1—epilepsy syndrome	4.19e-06	0.000127	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TH—epilepsy syndrome	4.17e-06	0.000126	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.11e-06	0.000124	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.1e-06	0.000124	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.05e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.04e-06	0.000122	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—epilepsy syndrome	4.01e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.99e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.99e-06	0.000121	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.92e-06	0.000119	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.91e-06	0.000119	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.91e-06	0.000118	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—epilepsy syndrome	3.89e-06	0.000118	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.89e-06	0.000118	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.88e-06	0.000118	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.8e-06	0.000115	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—epilepsy syndrome	3.79e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.76e-06	0.000114	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TH—epilepsy syndrome	3.75e-06	0.000114	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.71e-06	0.000112	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.69e-06	0.000112	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.69e-06	0.000112	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.67e-06	0.000111	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TH—epilepsy syndrome	3.66e-06	0.000111	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SRC—epilepsy syndrome	3.65e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.61e-06	0.000109	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.56e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.55e-06	0.000107	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.55e-06	0.000107	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SRC—epilepsy syndrome	3.49e-06	0.000106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—epilepsy syndrome	3.48e-06	0.000106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAT—epilepsy syndrome	3.44e-06	0.000104	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	3.4e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.36e-06	0.000102	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—epilepsy syndrome	3.34e-06	0.000101	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—epilepsy syndrome	3.34e-06	0.000101	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.17e-06	9.59e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.13e-06	9.48e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—epilepsy syndrome	3.11e-06	9.42e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.1e-06	9.4e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.09e-06	9.35e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.05e-06	9.25e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAT—epilepsy syndrome	3.01e-06	9.12e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3e-06	9.09e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	8.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.89e-06	8.76e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.82e-06	8.54e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.8e-06	8.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.79e-06	8.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AGT—epilepsy syndrome	2.73e-06	8.26e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.72e-06	8.25e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—epilepsy syndrome	2.67e-06	8.09e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.66e-06	8.07e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.53e-06	7.66e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.45e-06	7.41e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.43e-06	7.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.41e-06	7.29e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.4e-06	7.26e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.4e-06	7.26e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AGT—epilepsy syndrome	2.39e-06	7.24e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—epilepsy syndrome	2.34e-06	7.09e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—epilepsy syndrome	2.29e-06	6.95e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.29e-06	6.93e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—epilepsy syndrome	2.27e-06	6.87e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.26e-06	6.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.25e-06	6.83e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—epilepsy syndrome	2.17e-06	6.57e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.13e-06	6.44e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.06e-06	6.24e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—epilepsy syndrome	2.01e-06	6.09e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.88e-06	5.7e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.88e-06	5.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.86e-06	5.62e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—epilepsy syndrome	1.83e-06	5.55e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—epilepsy syndrome	1.83e-06	5.54e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.81e-06	5.47e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.68e-06	5.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.64e-06	4.98e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.6e-06	4.86e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.48e-06	4.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.47e-06	4.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.44e-06	4.37e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.24e-06	3.75e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.13e-06	3.42e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.07e-06	3.24e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.88e-07	2.99e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—epilepsy syndrome	9.2e-07	2.79e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.26e-07	2.5e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.06e-07	2.44e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.97e-07	1.5e-05	CbGpPWpGaD
